Yeast NDI1 improves oxidative phosphorylation capacity and increases protection against oxidative stress and cell death in cells carrying a Leber's hereditary optic neuropathy mutation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 5, 2007, Pages 533-542

  Park, Jeong Soon ^a   Li, You fen ^a   Bai, Yidong ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Apoptosis; Complex I; LHON; Mitochondrial; NDI1; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL DNA; GALACTOSE; GENOMIC DNA; GLUCOSE; MESSENGER RNA; MITOCHONDRIAL DNA; PARAQUAT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); ROTENONE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE DISEASE; OXIDATIVE PHOSPHORYLATION; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; YEAST;

ADENOSINE TRIPHOSPHATE; CELL DEATH; CELL LINE, TUMOR; CELL RESPIRATION; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; HUMANS; MITOCHONDRIA; MUTATION; NADH DEHYDROGENASE; OPTIC ATROPHY, HEREDITARY, LEBER; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSFECTION;

SACCHAROMYCES CEREVISIAE;

EID: 34247118250     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.01.009     Document Type: Article

References (62)

1. Yagi T., Seo B.B., Di Bernardo S., Nakamaru-Ogiso E., Kao M.C., and Matsuno-Yagi A. NADH dehydrogenases: from basic science to biomedicine. J. Bioenerg. Biomembr. 33 (2001) 233-242
2. Walker J.E. The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. Q. Rev. Biophys. 25 (1992) 253-324
3. Carroll J., Shannon R.J., Fearnley I.M., Walker J.E., and Hirst J. Definition of the nuclear encoded protein composition of bovine heart mitochondrial complex I. Identification two new subunits. J. Biol. Chem. 277 (2002) 50311-50317
4. Chomyn A., Mariottini P., Cleeter M.W., Ragan C.I., Matsuno-Yagi A., Hatefi Y., Doolittle R.F., and Attardi G. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 314 (1985) 592-597
5. Chomyn A., Cleeter M.W., Ragan C.I., Riley M., Doolittle R.F., and Attardi G. URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science 234 (1986) 614-618
6. Loeffen J.L., Smeitink J.A., Trijbels J.M., Janssen A.J., Triepels R.H., Sengers R.C., and van den Heuvel L.P. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum. Mutat. 15 (2000) 123-134
7. Schapira A.H. Human complex I defects in neurodegenerative diseases. Biochim. Biophys. Acta 1364 (1998) 261-270
8. Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 3 (2001) 119-125
9. Leber T. Uber hereditare und congenital-angelegte Sehnervenleiden. Graefes Arch. Ophthalmol. 17 (1871) 249-291
10. Nikoskelainen E. New aspects of the genetic, etiologic, and clinical puzzle of Leber's disease. Neurology 34 (1984) 1482-1484
11. Seedorff T. The inheritance of Leber's disease. A genealogical follow-up study. Acta Ophthalmol. (Copenh.) 63 (1985) 135-145
12. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas II L.J., and Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242 (1988) 1427-1430
13. Howell N., Halvorson S., Kubacka I., McCullough D.A., Bindoff L.A., and Turnbull D.M. Mitochondrial gene segregation in mammals: is the bottleneck always narrow?. Hum. Genet. 90 (1992) 117-120
14. Huoponen K., Vilkki J., Aula P., Nikoskelainen E.K., and Savontaus M.L. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am. J. Hum. Genet. 48 (1991) 1147-1153
15. Mackey D., and Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am. J. Hum. Genet. 51 (1992) 1218-1228
16. Howell N. Leber hereditary optic neuropathy: mitochondrial mutations and degeneration of the optic nerve. Vision Res. 37 (1997) 3495-3507
17. Chalmers R.M., and Schapira A.H. Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy. Biochim. Biophys. Acta 1410 (1999) 147-158
18. Man P.Y., Turnbull D.M., and Chinnery P.F. Leber hereditary optic neuropathy. J. Med. Genet. 39 (2002) 162-169
19. Larsson N.G., Andersen O., Holme E., Oldfors A., and Wahlstrom J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann. Neurol. 30 (1991) 701-708
20. Hofhaus G., Johns D.R., Hurko O., Attardi G., and Chomyn A. Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. J. Biol. Chem. 271 (1996) 13155-13161
21. De Vries S., Van Witzenburg R., Grivell L.A., and Marres C.A. Primary structure and import pathway of the rotenone-insensitive NADH-ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur. J. Biochem. 203 (1992) 587-592
22. Marres C.A., de Vries S., and Grivell L.A. Isolation and inactivation of the nuclear gene encoding the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur. J. Biochem. 195 (1991) 857-862
23. de Vries S., and Grivell L.A. Purification and characterization of a rotenone-insensitive NADH:Q6 oxidoreductase from mitochondria of Saccharomyces cerevisiae. Eur. J. Biochem. 176 (1988) 377-384
24. Kitajima-Ihara T., and Yagi T. Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells. FEBS Lett. 421 (1998) 37-40
25. Seo B.B., Kitajima-Ihara T., Chan E.K., Scheffler I.E., Matsuno-Yagi A., and Yagi T. Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9167-9171
26. Seo B.B., Matsuno-Yagi A., and Yagi T. Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae. Biochim. Biophys. Acta 1412 (1999) 56-65
27. Bai Y., Hajek P., Chomyn A., Chan E., Seo B.B., Matsuno-Yagi A., Yagi T., and Attardi G. Lack of Complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene. J. Biol. Chem. 276 (2001) 38808-38813
28. Chen C.A., and Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechniques 6 (1988) 632-638
29. Bai Y., Shakeley R.M., and Attardi G. Tight control of respiration by NADH dehydrogenase ND5 subunit gene expression in mouse mitochondria. Mol. Cell. Biol. 20 (2000) 805-815
30. Deng J.H., Li Y., Park J.S., Wu J., Hu P., Lechleiter J., and Bai Y. Nuclear suppression of mitochondrial defects in cells without the ND6 subunit. Mol. Cell. Biol. 26 (2006) 1077-1086
31. Zheng X.X., Shoffner J.M., Voljavec A.S., and Wallace D.C. Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochim. Biophys. Acta 1019 (1990) 1-10
32. Birch-Machin M.A., and Turnbull D.M. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 65 (2001) 97-117
33. Nijtmans L.G., Henderson N.S., and Holt I.J. Blue Native electrophoresis to study mitochondrial and other protein complexes. Methods 26 (2002) 327-334
34. Schagger H. Electrophoretic techniques for isolation and quantification of oxidative phosphorylation complexes from human tissues. Methods Enzymol. 264 (1996) 555-566
35. Manfredi G., Spinazzola A., Checcarelli N., and Naini A. Assay of mitochondrial ATP synthesis in animal cells. Methods Cell Biol. 65 (2001) 133-145
36. Degli Esposti M., and McLennan H. Mitochondria and cells produce reactive oxygen species in virtual anaerobiosis: relevance to ceramide-induced apoptosis. FEBS Lett. 430 (1998) 338-342
37. Bai Y., Hu P., Park J.S., Deng J.H., Song X., Chomyn A., Yagi T., and Attardi G. Genetic and functional analysis of mitochondrial DNA-encoded complex I genes. Ann. N. Y. Acad. Sci. 1011 (2004) 272-283
38. Schagger H. Native electrophoresis for isolation of mitochondrial oxidative phosphorylation protein complexes. Methods Enzymol. 260 (1995) 190-202
39. Albers D.S., and Beal M.F. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural Transm., Suppl. 59 (2000) 133-154
40. Wong A., and Cortopassi G. mtDNA mutations confer cellular sensitivity to oxidant stress that is partially rescued by calcium depletion and cyclosporin A. Biochem. Biophys. Res. Commun. 239 (1997) 139-145
41. Morita I., Smith W.L., DeWitt D.L., and Schindler M. Expression-activity profiles of cells transfected with prostaglandin endoperoxide H synthase measured by quantitative fluorescence microscopy. Biochemistry 34 (1995) 7194-7199
42. Howell N. Leber hereditary optic neuropathy: how do mitochondrial DNA mutations cause degeneration of the optic nerve?. J. Bioenerg. Biomembr. 29 (1997) 165-173
43. Ciriolo M.R., Aquilano K., De Martino A., Carri M.T., and Rotilio G. Differential role of superoxide and glutathione in S-nitrosoglutathione-mediated apoptosis: a rationale for mild forms of familial amyotrophic lateral sclerosis associated with less active Cu, Zn superoxide dismutase mutants. J. Neurochem. 77 (2001) 1433-1443
44. Baracca A., Solaini G., Sgarbi G., Lenaz G., Baruzzi A., Schapira A.H., Martinuzzi A., and Carelli V. Severe impairment of complex I-driven adenosine triphosphate synthesis in Leber hereditary optic neuropathy cybrids. Arch. Neurol. 62 (2005) 730-736
45. Brown M.D. The enigmatic relationship between mitochondrial dysfunction and Leber's hereditary optic neuropathy. J. Neurol. Sci. 165 (1999) 1-5
46. Carelli V., Rugolo M., Sgarbi G., Ghelli A., Zanna C., Baracca A., Lenaz G., Napoli E., Martinuzzi A., and Solaini G. Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: a model of mitochondrial neurodegeneration. Biochim. Biophys. Acta 1658 (2004) 172-179
47. Guy J., Qi X., Pallotti F., Schon E.A., Manfredi G., Carelli V., Martinuzzi A., Hauswirth W.W., and Lewin A.S. Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann. Neurol. 52 (2002) 534-542
48. Yagi T. Bacterial NADH-quinone oxidoreductases. J. Bioenerg. Biomembr. 23 (1991) 211-225
49. Acin-Perez R., Bayona-Bafaluy M.P., Fernandez-Silva P., Moreno-Loshuertos R., Perez-Martos A., Bruno C., Moraes C.T., and Enriquez J.A. Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol. Cell 13 (2004) 805-815
50. Schagger H., de Coo R., Bauer M.F., Hofmann S., Godinot C., and Brandt U. Significance of respirasomes for the assembly/stability of human respiratory chain complex I. J. Biol. Chem. 279 (2004) 36349-36353
51. Schagger H. Respiratory chain supercomplexes. IUBMB Life 52 (2001) 119-128
52. Yagi T., Seo B.B., Nakamaru-Ogiso E., Marella M., Barber-Singh J., Yamashita T., and Matsuno-Yagi A. Possibility of transkingdom gene therapy for complex I diseases. Biochim. Biophys. Acta (2006) 708-714
53. Yagi T., Seo B.B., Nakamaru-Ogiso E., Marella M., Barber-Singh J., Yamashita T., Kao M.C., and Matsuno-Yagi A. Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?. Rejuvenation Res. 9 (2006) 191-197
54. Wong A., Cavelier L., Collins-Schramm H.E., Seldin M.F., McGrogan M., Savontaus M.L., and Cortopassi G.A. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum. Mol. Genet. 11 (2002) 431-438
55. Qi X., Lewin A.S., Hauswirth W.W., and Guy J. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest. Ophthalmol. Visual Sci. 44 (2003) 1088-1096
56. Beretta S., Mattavelli L., Sala G., Tremolizzo L., Schapira A.H., Martinuzzi A., Carelli V., and Ferrarese C. Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain 127 (2004) 2183-2192
57. Ghelli A., Zanna C., Porcelli A.M., Schapira A.H., Martinuzzi A., Carelli V., and Rugolo M. Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J. Biol. Chem. 278 (2003) 4145-4150
58. Zanna C., Ghelli A., Porcelli A.M., Martinuzzi A., Carelli V., and Rugolo M. Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and endonuclease G. Apoptosis 10 (2005) 997-1007
59. Danielson S.R., Wong A., Carelli V., Martinuzzi A., Schapira A.H., and Cortopassi G.A. Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-Induced apoptosis. J. Biol. Chem. 277 (2002) 5810-5815
60. Seo B.B., Wang J., Flotte T.R., Yagi T., and Matsuno-Yagi A. Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells. J. Biol. Chem. 275 (2000) 37774-37778
61. Seo B.B., Nakamaru-Ogiso E., Flotte T.R., Yagi T., and Matsuno-Yagi A. A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition. Mol. Ther. 6 (2002) 336-341
62. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., and Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23 (2003) 10756-10764